web triage
web triage with http://www.md-news.net

web triage

MD News

News for 16-Sep-25

Source: MedicineNet Senior Health General
Elder Abuse Often Missed In ER

Source: MedicineNet Prevention and Wellness General
Foods Might Serve Up High Levels of Chemicals Found in Plastics

Source: MedicineNet Senior Health General
1 in 4 Seniors Doesn't Discuss End-of-Life Care

Source: MedicineNet Senior Health General
Prices Skyrocket on Drugs Widely Used by Seniors: Report

Search the Web
web triage
beauregard
employee health web site
health tools
internet health care
internet health care links
internet health information
internet health resources
internet health service
medical diagnostic systems

The Best web triage website

All the web triage information you need to know about is right here. Presented and researched by http://www.md-news.net. We've searched the information super highway far and wide to provide you with the best web triage site on the internet today. The links below will assist you in your efforts to find the information that you are looking for about
web triage.

web triage

MD News
Need information on medical news? Follow our sponsored links to find information on all of your medical new needs.
MD News

Research data about web triage is often cited by general-interest publications like USA Today and network newscasts. You don't need a Fortune 500 sized budget to undertake a newsworthy study, or to receive coverage for it, either to your industry or the general public. But you do not know that the web triage is the perfect fit for you with all of the data available.

When conducting research on web triage quite often I will discover something that sets me on fire. That's what happened when I discovered these web triage websites and that is the purpose of our site - to share this with our visitors. and build relationships without the benefit of seeing, hearing or touching those we associate with.

web triage

MD News
Need information on medical news? Follow our sponsored links to find information on all of your medical new needs.
MD News

You may or may not be at the page that has everything you're looking for right now, because our web triage site is too new to be the best in the field, or even in the top 10 websites. But the Internet sites that we link to above are the leaders of the pack. We know that they are the very best because we've done an awful lot of time consuming research over the past few months to come up with the very best web triage resources available.

So what we suggest you do is leave our humble attempt at a web triage site for one of our recommended choices. You'll find exactly the information and help about web triage that you are seeking, and we'll have the satisfaction of helping you find what you are looking for.

Treating Chronic Mutational Hepatitis B with Chinese Medicine Vitalliver (Vigconic Suppositories)

 by: ZHANG GUAN HUA, LIANG CHAO, ZHENG WAN PIN

Treating chronic mutational hepatitis B with Chinese medicine Vitalliver (Vigconic suppositories)


ZHANG GUAN HUA, LIANG CHAO, ZHENG WAN PIN


Chengdu University of TCM, Hepatitis Laboratory in the attached hospital of Chengdu University of TCM, Sichuan, China

Research Method:

Quantitative determination by contrasting HBV-DNA of cases before and after the treatment.

Number of cases: 25 (n)

Case Selection: Between the age of 16 and 65, in accordance with the diagnosis standards pf chronic Hepatitis B, with negative e antigen and positive e antibody, HBV-DNA > 1×104 cp/mL.

Detection Method: All the blood samples are detected by Sichuan Clinical Detection Center; PCR-ELISA quantitative determination is used within detection range of 1×104 - 1×107-8, HBV-DNA, unit of measurement is cp/mL.

Direction Plan: one suppository provided by Vigconic (International) Ltd. Bid. The course of treatment is six months, the tracing observation after withdrawal lasts six months.

Observation index:

  1. HBV-DNA response after the treatment.

  2. Lasting HBV-DNA response (six months after withdrawal).

Criterion of Therapeutic Effect:

  1. If HBV-DNA volume 1×104 cp/mL: 4/25 (16%)

  2. Lasting response:

HBV-DNA volume 1×104 cp/mL: 2/25 (8%)

Among the results of lasting response, 16 blood serum samples are detected through fluorimetric quantitative determination PCR by the instruments of PE.USD, H-7700 in the second attached hospital of Guangzhou Medical College. The result is in accordance with that in Sichuan Clinical Testing Center. (8 cases among it < 1×102 cp/mL). The testing range of this testing method is 1×102 - 1×107-8 cp/mL.

Conclusion

The reason for the repeatedly abnormal liver function of Chronic Hepatitis B (CHB) patients lies in the repeatedly duplication of HBV after infection, which leads to fibrosis of liver, then cirrhosis and liver cancer. It is commonly accepted that if CHB shows the transformation of HBeAg/Anti-HBe, HBV-DNA becoming negative, liver function returning to normal state, the disease is relieved. However, parts of patients with the transformation of HBeAg/Anti-HBe still remain positive in HBV-DNA and the pathological change in the liver continues. Because HBV-DNA occurs promoter mutation in the anterior C section (1896 necleoside G-A variation) or in the C section (1762 nucleoside T variation, 1764 G-A variation), HBeAg cannot come into being. Therefore, the HBeAg in the patient's blood cannot be detected, while the virus can keep on duplicating and fixing itself. Through sequential assay of nucleic acid, it proves that promoter mutation appears in 30%-60% of HBeAg negative Chronic Hepatitis B (CHB) in the anterior C section or in the C section. In some provinces and cities of the People of China, the percentage of promoter mutation appears in HBeAg negative Chronic Hepatitis B (CHB) in the anterior C section or in the C section is from 17.6% to 78.9%. Eight out of the 25 cases of our observation go through the sequential assay of nucleic acid carried out by the Department of Microbiology of the University of Hong Kong. It all proves to have HBV-DNA mutation. The chronic mutational Hepatitis B is infectious and apt to cause cirrhosis and liver cancer since the present medicines of antivirus and immuno-modulator do not produce the expected therapeutic effects.

Vitalliver suppository is made up from a formula of Chinese herbs, including Ginseng, Deer Horn, Cordyceps, Radix Astragali, Frudctus Cnidii, Semen Cuscutae, etc. The formula is mainly for strengthening the body resistant and primarily for reinforcing Kidney Qi, which produces good therapeutic effects in treating chronic mutational Hepatitis B. The mechanism is probably that through the regulating of immune system, the duplication of virus is inhibited and meanwhile the liver is protected, so it can produce a lasting therapeutic effect. No adverse reaction and severe accident happens during clinical observation, so it is safe for using. Vitalliver is bringing hopes to the treatment of chronic mutational Hepatitis B.

* The second stage of clinical trial would be carrying out by the Microbiology Department of the University of Hong Kong and Chengdu University of Traditional Chinese Medicine.

For more information, please visit: http://www.vigconic.com


Or, contact:


William Yip cs@vigconic.com


5/F, Cheung Wah Building, Sheung Heung Rd,


Kowloon, Hong Kong


Tel: 852-27656200


Fax: 852-27645314

About The Author

Chengdu University of TCM, Hepatitis Laboratory in the attached hospital of Chengdu University of TCM, Sichuan, China


webmaster@vigconic.com

Google

http://www.medmeet.com/
Listen On The Net | Medical Meetings On The Net | Take Medicine Correctly | Medical Presentations | Fantasy Football Information

Internet Meetings   medical mailings   Medical Newscast